Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.
Oral candidiasis in patients with psoriasis: correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment.
Picciani BL, Michalski-Santos B, Carneiro S, Sampaio AL, Avelleira JC, Azulay DR, Pinto JM, Dias EP
Department of Pathology, Fluminense Federal University, Rio de Janeiro, Brazil. email@example.com
Published 17 May 2013 in J Am Acad Dermatol, 68(6): 986-91.
Articles on Psoriasis published 17 May 2013:
Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol, 68(6): 992-9.
Patients' educational needs about topical treatments for psoriasis. J Am Acad Dermatol, 68(6): e163-8.
Articles on Psoriasis published 16 May 2013:
Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients? JAMA, 309(19): 2043-4.
Articles on Psoriasis published 29 April 2013:
Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence. J Dermatolog Treat, 24(3): 199-208.
The treatment of psoriasis requires long-lasting intervention. Conventional treatments for psoriasis comprise topical, phototherapeutic and systemic modalities, such as methotrexate or cyclosporine. Biological therapies are advocated by treatment guidelines for the use in moderate-to-severe psoriasis, when conventional treatments have failed, are contraindicated or are associated with severe adverse events. Etanercept is an anti-TNF recombinant fusion protein that has emerged as a standard ... [Abstract] [Full-text]
Long-term management of scalp psoriasis: perspectives from the International Psoriasis Council. J Dermatolog Treat, 24(3): 188-92.
The scalp is a well-known predilection site for psoriasis. Epidemiological data on the various manifestations of scalp psoriasis as well as on its therapeutic management are sparse. The understanding of the natural course of scalp psoriasis is relevant for its therapeutic management. In over 25% of patients, scalp psoriasis is the first signal of the psoriatic condition. Nevertheless, few of the therapies currently used for the treatment of scalp psoriasis have been evaluated for efficacy in ... [Abstract] [Full-text]
Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatolog Treat, 24(3): 179-87.
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial). J Dermatolog Treat, 24(3): 169-78.
© 2004-2013 Psoriasis Research Today. All Rights Reserved.